About: Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.91 (-2.19%)
PBM NASDAQ Psyence Biomedical Ltd. Common Shares
Loading watchlist status…
Psyence Biomedical Ltd. Common Shares share price
PBM price activity
Last Price
$4.910
Change (24hr)
-0.11 USD (-2.19%)
Volume
15.06K
Volume (4w avg)
-
Open
$4.92
Day Range
$4.84 - $5.10
Previous Close
$5.02
Last Trade
07 Oct, 7:54 pm GMT+0
Delayed
07 Oct, 7:54 pm GMT+0
PBM price performance
-10.4%
5D
8.15%
1M
551.71%
YTD
38.31%
1Y
Delayed
07 Oct, 7:54 pm GMT+0
PBM Market Signals